Fifth Third Bancorp Intercept Pharmaceuticals, Inc. Transaction History

Fifth Third Bancorp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$15.46 - $24.5 $11,378 - $18,032	-736 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $3,965 - $6,880	-162 Reduced 18.04%	736 $18,000
Q3 2020 Nov 09, 2020	SELL	$39.09 - $53.44 $2,931 - $4,008	-75 Reduced 7.71%	898 $37,000
Q2 2020 Aug 05, 2020	SELL	$46.7 - $92.04 $5,837 - $11,505	-125 Reduced 11.38%	973 $47,000
Q1 2020 May 05, 2020	SELL	$48.35 - $118.68 $1,934 - $4,747	-40 Reduced 3.51%	1,098 $69,000
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $23,058 - $49,888	402 Added 54.62%	1,138 $141,000
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $82,993 - $103,755	-1,426 Reduced 65.96%	736 $43,000
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $68,412 - $142,500	1,200 Added 124.74%	2,162 $125,000
Q2 2017 Aug 11, 2017	BUY	N/A	962	962 $116,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.